Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

nhow Brussels Bloom

Nov 28, 2022 12:30 PM - Nov 29, 2022 6:00 PM

Rue Royale 250, 1210 Brussels, Belgium

DIA Health Technology Assessment (HTA) Forum

Session 3: European Methodology at the Heart of the HTA Regulation - What is required to achieve the outcomes?

Session Chair(s)

Lara  Wolfson

Lara Wolfson

AVP & Head, HTA Statistics, MSD Switzerland, Switzerland

Roisin  Adams

Roisin Adams

Deputy Head, National Centre for Pharmacoeconomics (NCPE), Ireland

The central question for this session is how can we adapt to meet the evolving space of new methodologies and technologies, and leverage modern tools and information visualization to support informed, patient and provider relevant assessments? 

Speaker(s)

Anne  Willemsen, MSc

The Process

Anne Willemsen, MSc

Senior Project Manager, Joint Production Co-Lead Partner - Pharmaceuticals, ZIN - National Health Care Institute, Netherlands

James  Ryan, MSc

Scene setting presentation: Case study in line with the importance of agreeing on joint methodologies for predictability

James Ryan, MSc

Director, Global HTA Policy , AstraZeneca (Global), UK, United Kingdom

Beate  Wieseler

National HTA Agencies Perspective

Beate Wieseler

Head of Department, Institute for Quality and Efficiency in Health Care , IQWiG, Germany

Anja  Schiel, PhD

National HTA Agencies Perspective

Anja Schiel, PhD

Special Advisor, Lead Methodologist/Statistician; NOMA, Norwegian Medical Products Agency (NOMA), Norway

Steffen  Thirstrup, MD

EMA Perspective

Steffen Thirstrup, MD

Chief Medical Officer, European Medicines Agency, Netherlands

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.